CN104740158A - Medicine for treating hyperthyroidism - Google Patents

Medicine for treating hyperthyroidism Download PDF

Info

Publication number
CN104740158A
CN104740158A CN201310748308.XA CN201310748308A CN104740158A CN 104740158 A CN104740158 A CN 104740158A CN 201310748308 A CN201310748308 A CN 201310748308A CN 104740158 A CN104740158 A CN 104740158A
Authority
CN
China
Prior art keywords
parts
medicine
radix
hyperthyroidism
treating hyperthyroidism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310748308.XA
Other languages
Chinese (zh)
Inventor
黄思齐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310748308.XA priority Critical patent/CN104740158A/en
Publication of CN104740158A publication Critical patent/CN104740158A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating hyperthyroidism. The medicine is prepared from the following raw materials in parts by weight: 25-35 parts of radix astragali, 8-12 parts of radix pseudostellariae, 8-12 parts of dried rehamnnia root, 8-12 parts of radix paeoniae alba, 8-12 parts of fruit of Chinese magnoliavine, 8-12 parts of selfheal, 8-12 parts of fried wild jujube seed, 20-30 parts of raw fossil fragments, 20-30 parts of raw oyster, 20-30 parts of semen cassiae torae, 8-12 parts of pinellia ternate and 8-12 parts of pericarpium citri reticulatae. The medicine for treating hyperthyroidism disclosed by the invention is prepared by combining 12 natural traditional Chinese medicines, and various crude medicines are cooperated to take effects of removing heat to cool blood, tonifying spleen and benefiting lung, regulating qi for strengthening spleen, nourishing yin and moistening lung, calming liver and suppressing yang, and tranquilizing with heavy material; the medicine has an inhibitory effect on both bacteria and viruses and treats both cause and symptoms, and the medicine is good in effect on treating hyperthyroidism and is free from toxic and side effects; and the medicine is simple in preparation method, relatively short in treatment course, convenient in administration and low in cost, and effective rate is above 90%.

Description

A kind of medicine for the treatment of hyperthyroidism
Technical field
The present invention relates to Chinese medicine, specifically a kind of medicine for the treatment of hyperthyroidism.
Background technology
Hyperthyroidism refers to and the thyrotoxicosis that thyroid glands generation thyroxin itself too much causes is called for short hyperthyroidism.Clinical have typical case's " three-many-one-little " symptom, namely polydipsia, polyphagia, polyuria, become thin.Hyperthyroidism is a kind of commonly encountered diseases, frequently-occurring disease, is a kind of difficult miscellaneous diseases healed compared with refractory, though be not pertinacious disease, because people are familiar with deficiency, often ignores treatment.Because thyroid hormone secretion too much causes hypermetabolism disease, make reason hyperthyroidism symptom increase the weight of suddenly to reach life-threatening a kind of state, main manifestations is high heat, profuse sweating, extremely tachycardia, vomiting, diarrhoea, dysphoria, and severe one is gone into a coma, as rescued not in time, death can be caused.Doctor trained in Western medicine generally takes bendazol, thiamazole.But it is long that the time limit taken by Western medicine, generally take 3-9 month, and toxic side effect, need to make regular check on Liver and kidney function.
The traditional Chinese medical science is thought, hyperthyroidism is caused by hyperactivity of fire caused by deficiency of YIN, asthenia of pulmonosplenic qi.
Summary of the invention
The medicine of the treatment hyperthyroidism the object of this invention is to provide a kind of good effect, the course for the treatment of is shorter, cost is low, having no side effect.
The technical scheme realizing the object of the invention is:
Treating a medicine for hyperthyroidism, is be made up of the raw material of following weight proportioning:
Radix Astragali 25-35 part, Radix Pseudostellariae 8-12 part, Radix Rehmanniae 8-12 part, Radix Paeoniae Alba 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Spica Prunellae 8-12 part, Semen Ziziphi Spinosae (parched) 8-12 part, Os Draconis 20-30 part, Concha Ostreae 20-30 part, Semen Cassiae 20-30 part, Rhizoma Pinelliae 8-12, Pericarpium Citri Reticulatae 8-12 part.
Preferably, the optimum weight proportioning of each raw material is:
The Radix Astragali 30 parts, Radix Pseudostellariae 10 parts, 10 parts, the Radix Rehmanniae, Radix Paeoniae Alba 10 parts, Fructus Schisandrae Chinensis 10 parts, Spica Prunellae 10 parts, Semen Ziziphi Spinosae (parched) 10 parts, Os Draconis 25 parts, Concha Ostreae 25 parts, Semen Cassiae 25 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts.
Described crude drug is in shop of Chinese medicines and commercially available.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, and concrete grammar is: take each crude drug by weight ratio, adds the water of 5-10 times of crude drug total amount, boils rear slow fire and boils 10-20 minute, filter and remove residue, to obtain final product with big fire.
Instructions of taking: every day three times, each 15 milliliters, general 2 weeks namely effective.
Medicine of the present invention also can be made into pill, powder or capsule.
In the present invention, effect of each crude drug is as follows:
The Radix Astragali: sweet in the mouth, slightly warm in nature.Gui Jing: return lung, spleen, liver, kidney channel.There is enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.
Radix Pseudostellariae: sweet, the micro-hardship of property is flat; Return spleen, lung meridian.Have body lubricant nature and, mend strengthening spleen and lung, tonifying QI to produce body fluid effect.
The Radix Rehmanniae: sweet in the mouth, cold in nature, GUIXIN, liver, kidney channel.There is heat clearing away, promote the production of body fluid, moisturize, tissue regeneration promoting, pain relieving, regulating menstruation, removing heat from blood, stop blooding, the effect such as to invigorate blood circulation.
Radix Paeoniae Alba: bitter in the mouth is sour, cool in nature, is slightly cold, has the effects such as easing the affected liver of enriching blood, suppressing the hyperactive liver pain relieving, yin fluid astringing receipts antiperspirant.
Fructus Schisandrae Chinensis: sour in the mouth, warm in nature, nontoxic, returns lung meridian, kidney channel.Have and astringe the lung, nourishing kidney, promote the production of body fluid, receive the effect such as antiperspirant, arresting seminal emission.
Semen Ziziphi Spinosae (parched): sweet in the mouth, property are flat, GUIXIN, spleen, liver, gallbladder meridian.There is nourishing the liver, mind calming, calm the nerves, the effects such as arresting sweating.
Spica Prunellae: bitter in the mouth, pungent, cold in nature, returns liver, gallbladder meridian.There is improving eyesight of relieving inflammation or internal heat, clearing away liver-fire, blood pressure lowering, mass dissipating and swelling eliminating, liver-wind of dispelling, network of passing through, row irritability, open effect of stagnation of liver-QI.
Os Draconis: sweet-puckery flavor, property are flat, enter the heart, liver, kidney channel.There is effect of subduing hyperactive YANG to ease mental disorders.
Concha Ostreae: salty in the mouth, cold nature, returns liver, gallbladder, kidney channel.There is the effects such as suppressing the hyperactive liver and subsiding YANG, tranquillization with heavy prescription, hard masses softening and resolving, convergence be astringent or styptic treatment for spontaneous sweating.
Semen Cassiae :bitter in the mouth, sweet and cool in nature, return liver, kidney, large intestine channel.There is the functions such as clearing away liver-fire, wind-damp dispelling, tonifying kidney and improving eyesight.
The Rhizoma Pinelliae: acrid in the mouth, warm in nature, returns spleen, stomach, lung meridian.There is the effects such as drying dampness to eliminate phlegm.
Pericarpium Citri Reticulatae: bitter in the mouth, pungent, warm in nature, returns lung, spleen channel.There is regulating qi-flowing for strengthening spleen, the effects such as drying dampness to eliminate phlegm.
12 kinds of natural Chinese medicine compatibilities chosen by the medicine that the present invention treats hyperthyroidism, each crude drug synergism plays the effects such as clearing away heat and cooling blood, invigorating the spleen to benefit the lung, regulating qi-flowing for strengthening spleen, nourishing YIN and moistening the lung, suppressing the hyperactive liver and subsiding YANG, tranquillization with heavy prescription, inhibitory action is had to virus and antibacterial, treating both the principal and the secondary aspects of a disease at the same time, effective to treatment hyperthyroidism, have no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, cost is low, and effective percentage reaches more than 90%.
Detailed description of the invention
Below in conjunction with embodiment, content of the present invention is further described, but is not limitation of the invention.
Embodiment 1:
Treat a medicine for hyperthyroidism, the weight proportion of each raw material is:
The Radix Astragali 25, Radix Pseudostellariae 8 parts, 8 parts, the Radix Rehmanniae, Radix Paeoniae Alba 8 parts, Fructus Schisandrae Chinensis 8 parts, Spica Prunellae 8 parts, Semen Ziziphi Spinosae (parched) 8 parts, Os Draconis 20 parts, Concha Ostreae 20 parts, Semen Cassiae 20 parts, the Rhizoma Pinelliae 8 parts, Pericarpium Citri Reticulatae 8-12 part.
Decoct into decoction oral according to a conventional method.
Embodiment 2:
Treat a medicine for hyperthyroidism, the weight proportion of each raw material is:
The Radix Astragali 30 parts, Radix Pseudostellariae 10 parts, 10 parts, the Radix Rehmanniae, Radix Paeoniae Alba 10 parts, Fructus Schisandrae Chinensis 10 parts, Spica Prunellae 10 parts, Semen Ziziphi Spinosae (parched) 10 parts, Os Draconis 25 parts, Concha Ostreae 25 parts, Semen Cassiae 25 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts.Decoct into decoction oral according to a conventional method.
Embodiment 3:
Treat a medicine for hyperthyroidism, the weight proportion of each raw material is:
The Radix Astragali 35 parts, Radix Pseudostellariae 12 parts, 12 parts, the Radix Rehmanniae, Radix Paeoniae Alba 12 parts, Fructus Schisandrae Chinensis 12 parts, Spica Prunellae 12 parts, Semen Ziziphi Spinosae (parched) 12 parts, Os Draconis 30 parts, Concha Ostreae 30 parts, Semen Cassiae 30 parts, the Rhizoma Pinelliae 12 parts, Pericarpium Citri Reticulatae 12 parts.Decoct into decoction oral according to a conventional method.
Experimental example:
In order to prove the clinical efficacy of medicine of the present invention further, selecting 30 routine patients, clinical observation is carried out to the curative effect of medicine of the present invention.
Efficacy determination based on transference cure, and changes situation with reference to effect etc., is divided into effective, effective and invalid.
Effective: symptom obviously alleviates and successful improves.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improvement or DeGrain.
Apply in Drug therapy hyperthyroidism 30 example of the present invention, man 12 example, female 18 example.Fundamental symptoms is: polydipsia, polyphagia, polyuria, become thin.After oral Drug therapy of the present invention, symptom all has certain improvement, wherein effective 27 examples, effective 29 examples, invalid 1 example, effective percentage 97%.

Claims (2)

1. treat a medicine for hyperthyroidism, it is characterized in that being made up of the raw material of following weight proportioning:
Radix Astragali 25-35 part, Radix Pseudostellariae 8-12 part, Radix Rehmanniae 8-12 part, Radix Paeoniae Alba 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Spica Prunellae 8-12 part, Semen Ziziphi Spinosae (parched) 8-12 part, Os Draconis 20-30 part, Concha Ostreae 20-30 part, Semen Cassiae 20-30 part, Rhizoma Pinelliae 8-12 part, Pericarpium Citri Reticulatae 8-12 part.
2. medicine according to claim 1, is characterized in that the weight proportion of each raw material is: the Radix Astragali 30 parts, Radix Pseudostellariae 10 parts, 10 parts, the Radix Rehmanniae, Radix Paeoniae Alba 10 parts, Fructus Schisandrae Chinensis 10 parts, Spica Prunellae 10 parts, Semen Ziziphi Spinosae (parched) 10 parts, Os Draconis 25 parts, Concha Ostreae 25 parts, Semen Cassiae 25 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts.
CN201310748308.XA 2013-12-31 2013-12-31 Medicine for treating hyperthyroidism Pending CN104740158A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310748308.XA CN104740158A (en) 2013-12-31 2013-12-31 Medicine for treating hyperthyroidism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310748308.XA CN104740158A (en) 2013-12-31 2013-12-31 Medicine for treating hyperthyroidism

Publications (1)

Publication Number Publication Date
CN104740158A true CN104740158A (en) 2015-07-01

Family

ID=53580779

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310748308.XA Pending CN104740158A (en) 2013-12-31 2013-12-31 Medicine for treating hyperthyroidism

Country Status (1)

Country Link
CN (1) CN104740158A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109010542A (en) * 2017-06-10 2018-12-18 鲍淳 A kind of drug for treating hyperthyroidism

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101549072A (en) * 2008-04-03 2009-10-07 韩杰 Traditional Chinese medicine composition for curing hyperthyrea
CN102038825A (en) * 2009-10-15 2011-05-04 张红旗 Formula of traditional Chinese medicine for treating hyperthyroidism

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101549072A (en) * 2008-04-03 2009-10-07 韩杰 Traditional Chinese medicine composition for curing hyperthyrea
CN102038825A (en) * 2009-10-15 2011-05-04 张红旗 Formula of traditional Chinese medicine for treating hyperthyroidism

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
潘瑞奇: "中西医结合治疗甲状腺功能亢进症115例", 《现代中西医杂志》 *
聂有智等: "中西医结合治疗甲状腺功能亢进症119例疗效观察", 《中级医刊》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109010542A (en) * 2017-06-10 2018-12-18 鲍淳 A kind of drug for treating hyperthyroidism

Similar Documents

Publication Publication Date Title
CN104162098A (en) Thyroid nodule eliminating paste preparation for treating benign non-toxic thyroid nodules and preparation method thereof
CN103055116B (en) Traditional Chinese medicine composition for treating acnes
CN103432559B (en) Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof
CN103330854B (en) Traditional Chinese medicine composition for treating nasal hemorrhage
CN101780220B (en) Traditional Chinese medicine for treating chronic gastritis
CN104491825B (en) A kind of Chinese medicine ointment for the treatment of oral ulcer
CN105194443A (en) Traditional Chinese medicine composition for treating infantile eczema and preparation method of composition
CN104740158A (en) Medicine for treating hyperthyroidism
CN106310150A (en) Chinese medicinal prescription for treatment of headache
CN105362634A (en) Medicine for treating female climacteric syndromes
CN104758674A (en) Traditional Chinese medicine composition for treating insomnia
CN104606523A (en) Traditional Chinese medicine composition treating children's measles
CN109010542A (en) A kind of drug for treating hyperthyroidism
CN102671032B (en) Traditional Chinese medicine for treating recurrent aphthae
CN100393349C (en) Analgetic
CN104906352A (en) Traditional Chinese medicine liquid for treating deficiency-fire flaring-up type infantile oral ulcer and preparation method thereof
CN106309807A (en) Traditional Chinese medicine composition for treating hyperthyroidism
CN105616895A (en) Traditional Chinese medicine preparation for treating coronary heart disease and preparation method
CN105412244A (en) Traditional Chinese medicine composition treating gynecological cervicitis
CN104887823A (en) Traditional Chinese medicine composition for treating nasopharyngeal carcinoma and administration method thereof
CN105288445A (en) Medicine for treating cervical bone hyperplasia
CN105477566A (en) Traditional Chinese medicine preparation for weight loss and detoxification
CN103585444A (en) Adjuvant pharmaceutical composition for treating goiter
CN105288326A (en) Insomnia treatment medicine
CN113842422A (en) Medicine for treating hysteromyoma and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150701

WD01 Invention patent application deemed withdrawn after publication